cyclovirobuxine-d has been researched along with Liver-Neoplasms* in 1 studies
1 other study(ies) available for cyclovirobuxine-d and Liver-Neoplasms
Article | Year |
---|---|
Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the
Hepatocellular carcinoma (HCC), the sixth most common malignancy worldwide, is characterized by a dismal prognosis due to high recurrence and metastasis rates. Thus, the need for the development of novel chemotherapeutic drugs is urgent. Cyclovirobuxine D (CVB-D), a steroidal alkaloid extracted from Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Epidermal Growth Factor; Focal Adhesion Protein-Tyrosine Kinases; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Snail Family Transcription Factors | 2020 |